NCT05416463

Brief Summary

This study will assess the clinical and health economic value of an intraoperative navigation system for total hip arthroplasty in one Ontario hospital. The results of this study will be used to generate evidence-based recommendations on the use and funding of the device in public hospitals and inform the development of a provincial healthcare innovation pathway.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 13, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

June 13, 2022

Status Verified

June 1, 2022

Enrollment Period

11 months

First QC Date

June 7, 2022

Last Update Submit

June 9, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Activities of Daily Living

    Hip disability and Osteoarthritis Outcome Score (HOOS) Scores are 1-100 and each subscale is scored and then connected with a line on a graph to generate a "HOOS profile". "0 indicates extreme problems and 100 indicates no problems."

    up to 12 months

Study Arms (2)

Control

SHAM COMPARATOR

The control group will receive primary elective THA as per standard of care surgical protocols for this type of surgery

Procedure: Intra-Operative Device for THA

Treatment

EXPERIMENTAL

The intervention group will receive primary elective THA with the use of Intellijoint HIP 3D mini-optical navigation tool.

Procedure: Intra-Operative Device for THA

Interventions

The intervention group will receive primary elective THA with the use of Intellijoint HIP 3D mini-optical navigation tool.

ControlTreatment

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Receiving primary THA
  • Elective THA
  • Provision of informed consent

You may not qualify if:

  • Unable to obtain informed consent
  • Receiving revision THA
  • THA is to treat trauma (i.e. hip fracture and/or dislocation)
  • Patient is undergoing simultaneous bilateral hip replacement
  • Performing surgeon is not participating in the study
  • Hip fracture
  • Hip dislocation
  • Severe osteoporosis
  • Trochanteric osteotomy
  • Suspected or actual infection
  • Existing implanted hardware
  • Severe deformities of the femoral or pelvic bone
  • High Body Mass Index (BMI)\*

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Tacrine

Intervention Hierarchy (Ancestors)

AminoacridinesAcridinesHeterocyclic Compounds, 3-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2022

First Posted

June 13, 2022

Study Start

July 1, 2022

Primary Completion

June 1, 2023

Study Completion

December 1, 2024

Last Updated

June 13, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share